← Every company

Sunshine Biopharma Inc SEC Filings

What Sunshine Biopharma Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

SBFM overview →
Filings on file
129
since Nov 14, 2016
Warning signs
23
latest Mar 31, 2026
Last results
Apr 9, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Oct 9, 2026
Material agreement
8-K
Read ↗
Oct 9, 2026
Share offering
424B4
Read ↗
Oct 2, 2026
Share offering
S-1
Read ↗
Sep 16, 2026
Shareholder vote
8-K
Read ↗
Aug 28, 2026
Share offering
S-1
Read ↗
Aug 28, 2026
Executive or director change
8-K
Read ↗
Aug 13, 2026
Quarterly report
10-Q
Read ↗
Jul 20, 2026
Material agreement
8-K
Read ↗
Jul 10, 2026
Material agreement
8-K
Read ↗
May 29, 2026
Shareholder vote
8-K
Read ↗
May 19, 2026
Material agreement
8-K
Read ↗
May 19, 2026
Share offering
424B4
Read ↗
May 13, 2026
Quarterly report
10-Q
Read ↗
May 12, 2026
Share offering
S-1
Read ↗
Apr 9, 2026
Results announced
8-K
Read ↗
Apr 3, 2026
Annual report
10-K
Read ↗
Mar 31, 2026
Late filing notice
NT 10-K
Read ↗
Feb 20, 2026
Shareholder vote
8-K
Read ↗
Feb 5, 2026
Executive or director change
8-K
Read ↗
Dec 12, 2025
Shareholder vote
8-K
Read ↗
Nov 13, 2025
Quarterly report
10-Q
Read ↗
Sep 30, 2025
Auditor change
8-K
Read ↗
Aug 12, 2025
Quarterly report
10-Q
Read ↗
Aug 5, 2025
Share offering
S-1
Read ↗
May 19, 2025
Results announced
8-K
Read ↗
May 15, 2025
Quarterly report
10-Q
Read ↗
Apr 3, 2025
Material agreement
8-K
Read ↗
Apr 2, 2025
Results announced
8-K
Read ↗
Apr 1, 2025
Annual report
10-K
Read ↗
Mar 31, 2025
Late filing notice
NT 10-K
Read ↗
Jan 15, 2025
Executive or director change
8-K
Read ↗
Dec 10, 2024
Shareholder vote
8-K
Read ↗
Nov 12, 2024
Share offering
424B4
Read ↗
Nov 7, 2024
Results announced
8-K
Read ↗
Nov 5, 2024
Quarterly report
10-Q
Read ↗
Oct 23, 2024
Executive or director change
8-K
Read ↗
Aug 20, 2024
Quarterly report
10-Q/A
Read ↗
Aug 19, 2024
Results announced
8-K
Read ↗
Aug 16, 2024
Quarterly report
10-Q
Read ↗
Aug 14, 2024
Late filing notice
NT 10-Q
Read ↗
Jul 2, 2024
Shareholder vote
8-K
Read ↗
Jun 7, 2024
Delisting notice or listing transfer
8-K
Read ↗
May 22, 2024
Results announced
8-K
Read ↗
May 20, 2024
Quarterly report
10-Q
Read ↗
May 15, 2024
Late filing notice
NT 10-Q
Read ↗
May 8, 2024
Auditor change
8-K
Read ↗
May 6, 2024
Auditor change
8-K
Read ↗
Apr 1, 2024
Results announced
8-K
Read ↗
Mar 28, 2024
Annual report
10-K
Read ↗
Mar 6, 2024
Material agreementUnregistered share saleShareholder vote
8-K
Read ↗
Mar 1, 2024
Delisting notice or listing transfer
8-K
Read ↗
Feb 16, 2024
Shareholder vote
8-K
Read ↗
Feb 15, 2024
Material agreement
8-K
Read ↗
Feb 14, 2024
Share offering
424B4
Read ↗
Feb 12, 2024
Material agreement
8-K
Read ↗
Feb 1, 2024
Share offering
S-1
Read ↗
Jan 30, 2024
Executive or director change
8-K
Read ↗
Dec 7, 2023
Shareholder vote
8-K
Read ↗
Nov 13, 2023
Results announced
8-K
Read ↗
Nov 13, 2023
Quarterly report
10-Q
Read ↗
Nov 2, 2023
Material agreement
8-K
Read ↗
Oct 20, 2023
Material agreement
8-K
Read ↗
Oct 13, 2023
Shareholder vote
8-K
Read ↗
Aug 11, 2023
Results announced
8-K
Read ↗
Aug 10, 2023
Quarterly report
10-Q
Read ↗
May 16, 2023
Material agreementUnregistered share sale
8-K
Read ↗
May 11, 2023
Results announced
8-K
Read ↗
May 10, 2023
Quarterly report
10-Q
Read ↗
Apr 4, 2023
Annual report
10-K
Read ↗
Mar 31, 2023
Late filing notice
NT 10-K
Read ↗
Mar 24, 2023
Delisting notice or listing transfer
8-K
Read ↗
Feb 28, 2023
Material agreement
8-K
Read ↗
Feb 10, 2023
Material agreement
8-K
Read ↗
Dec 9, 2022
Delisting notice or listing transfer
8-K
Read ↗
Nov 7, 2022
Quarterly report
10-Q
Read ↗
Oct 20, 2022
Executive or director changeAcquisition or sale completedMaterial agreementUnregistered share sale
8-K
Read ↗
Aug 3, 2022
Quarterly report
10-Q
Read ↗
May 6, 2022
Quarterly report
10-Q
Read ↗
Apr 28, 2022
Material agreementUnregistered share sale
8-K
Read ↗
Apr 8, 2022
Executive or director change
8-K
Read ↗
Mar 21, 2022
Annual report
10-K
Read ↗
Mar 15, 2022
Material agreementUnregistered share sale
8-K
Read ↗
Feb 25, 2022
Material agreement
8-K
Read ↗
Feb 17, 2022
Material agreement
8-K
Read ↗
Feb 17, 2022
Share offering
424B4
Read ↗
Dec 22, 2021
Unregistered share sale
8-K
Read ↗
Nov 9, 2021
Quarterly report
10-Q
Read ↗
Nov 3, 2021
Executive or director change
8-K
Read ↗
Sep 9, 2021
Share offering
S-1
Read ↗
Aug 9, 2021
Quarterly report
10-Q
Read ↗
May 11, 2021
Quarterly report
10-Q
Read ↗
Mar 30, 2021
Annual report
10-K
Read ↗
Nov 12, 2020
Quarterly report
10-Q
Read ↗
Oct 19, 2020
Material agreement
8-K
Read ↗
Sep 15, 2020
Material agreement
8-K
Read ↗
Aug 31, 2020
Quarterly report
10-Q/A
Read ↗
Aug 19, 2020
Quarterly report
10-Q
Read ↗
Aug 14, 2020
Late filing notice
NT 10-Q
Read ↗
Jun 24, 2020
Unregistered share sale
8-K
Read ↗
May 18, 2020
Quarterly report
10-Q
Read ↗
May 15, 2020
Late filing notice
NT 10-Q
Read ↗
May 1, 2020
Annual report
10-K
Read ↗
Mar 30, 2020
Late filing notice
NT 10-K
Read ↗
Nov 13, 2019
Quarterly report
10-Q
Read ↗
Aug 15, 2019
Quarterly report
10-Q
Read ↗
Aug 14, 2019
Late filing notice
NT 10-Q
Read ↗
Jul 19, 2019
Material agreement
8-K
Read ↗
May 20, 2019
Quarterly report
10-Q
Read ↗
May 14, 2019
Late filing notice
NT 10-Q
Read ↗
Apr 12, 2019
Annual report
10-K
Read ↗
Mar 29, 2019
Late filing notice
NT 10-K
Read ↗
Nov 16, 2018
Quarterly report
10-Q
Read ↗
Nov 14, 2018
Late filing notice
NT 10-Q
Read ↗
Oct 9, 2018
Share offering
S-1
Read ↗
Sep 14, 2018
Material agreement
8-K
Read ↗
Aug 17, 2018
Quarterly report
10-Q
Read ↗
Aug 14, 2018
Late filing notice
NT 10-Q
Read ↗
May 22, 2018
Quarterly report
10-Q
Read ↗
May 15, 2018
Late filing notice
NT 10-Q
Read ↗
Apr 2, 2018
Annual report
10-K
Read ↗
Jan 4, 2018
Material agreement
8-K
Read ↗
Nov 15, 2017
Quarterly report
10-Q
Read ↗
Nov 13, 2017
Late filing notice
NT 10-Q
Read ↗
Sep 5, 2017
Material agreement
8-K
Read ↗
Aug 11, 2017
Quarterly report
10-Q
Read ↗
May 12, 2017
Quarterly report
10-Q
Read ↗
Apr 17, 2017
Annual report
10-K
Read ↗
Mar 30, 2017
Late filing notice
NT 10-K
Read ↗
Nov 14, 2016
Quarterly report
10-Q
Read ↗

Source: Sunshine Biopharma Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on SBFM

Related datasets